Globeflex Capital’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-11,835
| Closed | -$928K | – | 521 |
|
|
2019
Q1 | $928K | Buy |
+11,835
| New | +$928K | 0.2% | 178 |
|
|
2016
Q3 | – | Sell |
-2,244
| Closed | -$167K | – | 518 |
|
|
2016
Q2 | $167K | Hold |
2,244
| – | – | 0.05% | 337 |
|
|
2016
Q1 | $150K | Hold |
2,244
| – | – | 0.04% | 330 |
|
|
2015
Q4 | $152K | Sell |
2,244
-7,855
| -78% | -$532K | 0.04% | 324 |
|
|
2015
Q3 | $540K | Buy |
+10,099
| New | +$540K | 0.12% | 278 |
|
|
2014
Q3 | – | Sell |
-32
| Closed | -$1K | – | 611 |
|
|
2014
Q2 | $1K | Sell |
32
-29,128
| -100% | -$910K | ﹤0.01% | 504 |
|
|
2014
Q1 | $1.22M | Sell |
29,160
-80
| -0.3% | -$3.36K | 0.14% | 183 |
|
|
2013
Q4 | $959K | Sell |
29,240
-161
| -0.5% | -$5.28K | 0.12% | 225 |
|
|
2013
Q3 | $793K | Hold |
29,401
| – | – | 0.1% | 238 |
|
|
2013
Q2 | $685K | Buy |
+29,401
| New | +$685K | 0.09% | 248 |
|